nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—ABCC2—epilepsy syndrome	0.0868	0.28	CbGaD
Irinotecan—BCHE—epilepsy syndrome	0.0815	0.263	CbGaD
Irinotecan—ABCG2—epilepsy syndrome	0.0768	0.247	CbGaD
Irinotecan—CES1—Rufinamide—epilepsy syndrome	0.0398	0.0871	CbGbCtD
Irinotecan—ALB—epilepsy syndrome	0.0335	0.108	CbGaD
Irinotecan—ABCB1—epilepsy syndrome	0.0319	0.103	CbGaD
Irinotecan—ABCC2—Levetiracetam—epilepsy syndrome	0.0204	0.0446	CbGbCtD
Irinotecan—UGT1A9—Propofol—epilepsy syndrome	0.0197	0.0431	CbGbCtD
Irinotecan—UGT1A1—Propofol—epilepsy syndrome	0.0161	0.0352	CbGbCtD
Irinotecan—UGT1A9—Valproic Acid—epilepsy syndrome	0.0141	0.0308	CbGbCtD
Irinotecan—ABCC1—Phenobarbital—epilepsy syndrome	0.0127	0.0277	CbGbCtD
Irinotecan—ABCC2—Carbamazepine—epilepsy syndrome	0.0117	0.0256	CbGbCtD
Irinotecan—ALB—Oxcarbazepine—epilepsy syndrome	0.0116	0.0254	CbGbCtD
Irinotecan—ABCC2—Phenytoin—epilepsy syndrome	0.0105	0.023	CbGbCtD
Irinotecan—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0104	0.0227	CbGbCtD
Irinotecan—ALB—Fosphenytoin—epilepsy syndrome	0.0102	0.0222	CbGbCtD
Irinotecan—ABCC2—Phenobarbital—epilepsy syndrome	0.00937	0.0205	CbGbCtD
Irinotecan—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00935	0.0204	CbGbCtD
Irinotecan—ALB—Clonazepam—epilepsy syndrome	0.0092	0.0201	CbGbCtD
Irinotecan—CYP2B6—Clobazam—epilepsy syndrome	0.009	0.0197	CbGbCtD
Irinotecan—CYP3A7—Carbamazepine—epilepsy syndrome	0.00783	0.0171	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00783	0.0171	CbGbCtD
Irinotecan—ALB—Rufinamide—epilepsy syndrome	0.0075	0.0164	CbGbCtD
Irinotecan—CYP2B6—Carbamazepine—epilepsy syndrome	0.00746	0.0163	CbGbCtD
Irinotecan—CYP3A7—Phenytoin—epilepsy syndrome	0.00702	0.0154	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00702	0.0154	CbGbCtD
Irinotecan—CYP2B6—Primidone—epilepsy syndrome	0.00696	0.0152	CbGbCtD
Irinotecan—CYP2B6—Phenytoin—epilepsy syndrome	0.00669	0.0146	CbGbCtD
Irinotecan—ABCB1—Levetiracetam—epilepsy syndrome	0.00666	0.0145	CbGbCtD
Irinotecan—ALB—Phenytoin—epilepsy syndrome	0.00655	0.0143	CbGbCtD
Irinotecan—CYP3A7—Phenobarbital—epilepsy syndrome	0.00626	0.0137	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00626	0.0137	CbGbCtD
Irinotecan—CYP2B6—Propofol—epilepsy syndrome	0.00624	0.0136	CbGbCtD
Irinotecan—CYP3A7—Midazolam—epilepsy syndrome	0.00617	0.0135	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00617	0.0135	CbGbCtD
Irinotecan—ALB—Propofol—epilepsy syndrome	0.00611	0.0134	CbGbCtD
Irinotecan—CYP2B6—Phenobarbital—epilepsy syndrome	0.00596	0.013	CbGbCtD
Irinotecan—CYP3A7—Diazepam—epilepsy syndrome	0.00593	0.013	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00593	0.013	CbGbCtD
Irinotecan—CYP2B6—Midazolam—epilepsy syndrome	0.00588	0.0128	CbGbCtD
Irinotecan—CYP3A5—Carbamazepine—epilepsy syndrome	0.00587	0.0128	CbGbCtD
Irinotecan—CYP2B6—Diazepam—epilepsy syndrome	0.00565	0.0124	CbGbCtD
Irinotecan—ALB—Diazepam—epilepsy syndrome	0.00554	0.0121	CbGbCtD
Irinotecan—CYP3A5—Phenytoin—epilepsy syndrome	0.00527	0.0115	CbGbCtD
Irinotecan—CYP3A5—Phenobarbital—epilepsy syndrome	0.0047	0.0103	CbGbCtD
Irinotecan—CYP3A5—Midazolam—epilepsy syndrome	0.00463	0.0101	CbGbCtD
Irinotecan—ABCB1—Clobazam—epilepsy syndrome	0.00461	0.0101	CbGbCtD
Irinotecan—CYP2B6—Valproic Acid—epilepsy syndrome	0.00445	0.00974	CbGbCtD
Irinotecan—CYP3A5—Diazepam—epilepsy syndrome	0.00445	0.00973	CbGbCtD
Irinotecan—ABCB1—Lamotrigine—epilepsy syndrome	0.00444	0.00971	CbGbCtD
Irinotecan—ABCB1—Carbamazepine—epilepsy syndrome	0.00382	0.00836	CbGbCtD
Irinotecan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00365	0.00797	CbGbCtD
Irinotecan—CYP3A5—Valproic Acid—epilepsy syndrome	0.00351	0.00767	CbGbCtD
Irinotecan—ABCB1—Phenytoin—epilepsy syndrome	0.00343	0.00749	CbGbCtD
Irinotecan—CYP3A4—Trimethadione—epilepsy syndrome	0.00339	0.00741	CbGbCtD
Irinotecan—CYP3A4—Felbamate—epilepsy syndrome	0.00339	0.00741	CbGbCtD
Irinotecan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00319	0.00697	CbGbCtD
Irinotecan—ABCB1—Phenobarbital—epilepsy syndrome	0.00306	0.00668	CbGbCtD
Irinotecan—ABCB1—Midazolam—epilepsy syndrome	0.00301	0.00659	CbGbCtD
Irinotecan—ABCB1—Diazepam—epilepsy syndrome	0.0029	0.00633	CbGbCtD
Irinotecan—CYP3A4—Clonazepam—epilepsy syndrome	0.00288	0.0063	CbGbCtD
Irinotecan—CYP3A4—Clobazam—epilepsy syndrome	0.00276	0.00604	CbGbCtD
Irinotecan—CYP3A4—Rufinamide—epilepsy syndrome	0.00235	0.00514	CbGbCtD
Irinotecan—CYP3A4—Carbamazepine—epilepsy syndrome	0.00229	0.00501	CbGbCtD
Irinotecan—CYP3A4—Primidone—epilepsy syndrome	0.00214	0.00467	CbGbCtD
Irinotecan—CYP3A4—Phenytoin—epilepsy syndrome	0.00205	0.00449	CbGbCtD
Irinotecan—CYP3A4—Propofol—epilepsy syndrome	0.00192	0.00419	CbGbCtD
Irinotecan—CYP3A4—Acetazolamide—epilepsy syndrome	0.00183	0.004	CbGbCtD
Irinotecan—CYP3A4—Phenobarbital—epilepsy syndrome	0.00183	0.004	CbGbCtD
Irinotecan—CYP3A4—Midazolam—epilepsy syndrome	0.00181	0.00395	CbGbCtD
Irinotecan—CYP3A4—Diazepam—epilepsy syndrome	0.00174	0.00379	CbGbCtD
Irinotecan—CYP3A4—Zonisamide—epilepsy syndrome	0.00169	0.0037	CbGbCtD
Irinotecan—Topotecan—ABCG2—epilepsy syndrome	0.00147	0.706	CrCbGaD
Irinotecan—CYP3A4—Valproic Acid—epilepsy syndrome	0.00137	0.00299	CbGbCtD
Irinotecan—CYP3A4—Topiramate—epilepsy syndrome	0.00123	0.0027	CbGbCtD
Irinotecan—SLC22A3—tongue—epilepsy syndrome	0.000757	0.0442	CbGeAlD
Irinotecan—TOP1MT—head—epilepsy syndrome	0.000672	0.0392	CbGeAlD
Irinotecan—TOP1MT—nervous system—epilepsy syndrome	0.000637	0.0372	CbGeAlD
Irinotecan—TOP1MT—central nervous system—epilepsy syndrome	0.000614	0.0358	CbGeAlD
Irinotecan—Topotecan—ABCB1—epilepsy syndrome	0.000613	0.294	CrCbGaD
Irinotecan—TOP1MT—cerebellum—epilepsy syndrome	0.0006	0.035	CbGeAlD
Irinotecan—TOP1—telencephalon—epilepsy syndrome	0.00057	0.0332	CbGeAlD
Irinotecan—CES2—telencephalon—epilepsy syndrome	0.000517	0.0301	CbGeAlD
Irinotecan—TOP1MT—brain—epilepsy syndrome	0.000487	0.0284	CbGeAlD
Irinotecan—TOP1—medulla oblongata—epilepsy syndrome	0.000448	0.0261	CbGeAlD
Irinotecan—ACHE—telencephalon—epilepsy syndrome	0.000425	0.0248	CbGeAlD
Irinotecan—TOP1—midbrain—epilepsy syndrome	0.000409	0.0239	CbGeAlD
Irinotecan—CES2—medulla oblongata—epilepsy syndrome	0.000406	0.0237	CbGeAlD
Irinotecan—TOP1—spinal cord—epilepsy syndrome	0.000399	0.0233	CbGeAlD
Irinotecan—CES2—midbrain—epilepsy syndrome	0.000371	0.0216	CbGeAlD
Irinotecan—CES2—spinal cord—epilepsy syndrome	0.000362	0.0211	CbGeAlD
Irinotecan—ACHE—medulla oblongata—epilepsy syndrome	0.000334	0.0195	CbGeAlD
Irinotecan—CES2—head—epilepsy syndrome	0.000322	0.0188	CbGeAlD
Irinotecan—TOP1—cerebellum—epilepsy syndrome	0.000316	0.0185	CbGeAlD
Irinotecan—ACHE—midbrain—epilepsy syndrome	0.000305	0.0178	CbGeAlD
Irinotecan—CES2—nervous system—epilepsy syndrome	0.000305	0.0178	CbGeAlD
Irinotecan—ACHE—spinal cord—epilepsy syndrome	0.000298	0.0174	CbGeAlD
Irinotecan—CES2—central nervous system—epilepsy syndrome	0.000294	0.0171	CbGeAlD
Irinotecan—CES2—cerebellum—epilepsy syndrome	0.000287	0.0167	CbGeAlD
Irinotecan—CES1—head—epilepsy syndrome	0.000265	0.0155	CbGeAlD
Irinotecan—TOP1—brain—epilepsy syndrome	0.000257	0.015	CbGeAlD
Irinotecan—CES1—nervous system—epilepsy syndrome	0.000251	0.0147	CbGeAlD
Irinotecan—ABCC1—telencephalon—epilepsy syndrome	0.000244	0.0142	CbGeAlD
Irinotecan—CES1—central nervous system—epilepsy syndrome	0.000242	0.0141	CbGeAlD
Irinotecan—ACHE—cerebellum—epilepsy syndrome	0.000236	0.0138	CbGeAlD
Irinotecan—BCHE—brainstem—epilepsy syndrome	0.000236	0.0137	CbGeAlD
Irinotecan—CES2—brain—epilepsy syndrome	0.000233	0.0136	CbGeAlD
Irinotecan—BCHE—forebrain—epilepsy syndrome	0.000227	0.0133	CbGeAlD
Irinotecan—BCHE—telencephalon—epilepsy syndrome	0.000209	0.0122	CbGeAlD
Irinotecan—ABCG2—telencephalon—epilepsy syndrome	0.000202	0.0118	CbGeAlD
Irinotecan—ACHE—brain—epilepsy syndrome	0.000192	0.0112	CbGeAlD
Irinotecan—CES1—brain—epilepsy syndrome	0.000192	0.0112	CbGeAlD
Irinotecan—SLC22A3—head—epilepsy syndrome	0.000184	0.0107	CbGeAlD
Irinotecan—SLC22A3—nervous system—epilepsy syndrome	0.000174	0.0102	CbGeAlD
Irinotecan—SLC22A3—central nervous system—epilepsy syndrome	0.000168	0.00979	CbGeAlD
Irinotecan—BCHE—medulla oblongata—epilepsy syndrome	0.000164	0.00958	CbGeAlD
Irinotecan—ABCG2—medulla oblongata—epilepsy syndrome	0.000159	0.00926	CbGeAlD
Irinotecan—BCHE—midbrain—epilepsy syndrome	0.00015	0.00876	CbGeAlD
Irinotecan—BCHE—spinal cord—epilepsy syndrome	0.000146	0.00855	CbGeAlD
Irinotecan—ABCG2—midbrain—epilepsy syndrome	0.000145	0.00847	CbGeAlD
Irinotecan—ABCG2—spinal cord—epilepsy syndrome	0.000142	0.00826	CbGeAlD
Irinotecan—ABCC1—cerebellum—epilepsy syndrome	0.000136	0.00791	CbGeAlD
Irinotecan—ALB—brain—epilepsy syndrome	0.000133	0.00779	CbGeAlD
Irinotecan—SLC22A3—brain—epilepsy syndrome	0.000133	0.00777	CbGeAlD
Irinotecan—BCHE—head—epilepsy syndrome	0.00013	0.0076	CbGeAlD
Irinotecan—BCHE—nervous system—epilepsy syndrome	0.000123	0.0072	CbGeAlD
Irinotecan—BCHE—central nervous system—epilepsy syndrome	0.000119	0.00693	CbGeAlD
Irinotecan—BCHE—cerebellum—epilepsy syndrome	0.000116	0.00678	CbGeAlD
Irinotecan—CYP2B6—head—epilepsy syndrome	0.000116	0.00677	CbGeAlD
Irinotecan—ABCG2—cerebellum—epilepsy syndrome	0.000112	0.00655	CbGeAlD
Irinotecan—ABCC1—brain—epilepsy syndrome	0.00011	0.00643	CbGeAlD
Irinotecan—CYP2B6—nervous system—epilepsy syndrome	0.00011	0.00642	CbGeAlD
Irinotecan—ABCB1—forebrain—epilepsy syndrome	0.000108	0.00632	CbGeAlD
Irinotecan—CYP2B6—central nervous system—epilepsy syndrome	0.000106	0.00618	CbGeAlD
Irinotecan—ABCB1—telencephalon—epilepsy syndrome	9.96e-05	0.00581	CbGeAlD
Irinotecan—BCHE—brain—epilepsy syndrome	9.43e-05	0.0055	CbGeAlD
Irinotecan—ABCG2—brain—epilepsy syndrome	9.12e-05	0.00532	CbGeAlD
Irinotecan—CYP2B6—brain—epilepsy syndrome	8.41e-05	0.00491	CbGeAlD
Irinotecan—CYP3A4—nervous system—epilepsy syndrome	8.31e-05	0.00485	CbGeAlD
Irinotecan—CYP3A4—central nervous system—epilepsy syndrome	8e-05	0.00467	CbGeAlD
Irinotecan—ABCB1—medulla oblongata—epilepsy syndrome	7.83e-05	0.00457	CbGeAlD
Irinotecan—ABCB1—midbrain—epilepsy syndrome	7.16e-05	0.00417	CbGeAlD
Irinotecan—ABCB1—spinal cord—epilepsy syndrome	6.98e-05	0.00407	CbGeAlD
Irinotecan—ABCB1—head—epilepsy syndrome	6.2e-05	0.00362	CbGeAlD
Irinotecan—ABCB1—nervous system—epilepsy syndrome	5.88e-05	0.00343	CbGeAlD
Irinotecan—ABCB1—central nervous system—epilepsy syndrome	5.66e-05	0.0033	CbGeAlD
Irinotecan—ABCB1—cerebellum—epilepsy syndrome	5.54e-05	0.00323	CbGeAlD
Irinotecan—ABCB1—brain—epilepsy syndrome	4.5e-05	0.00262	CbGeAlD
Irinotecan—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	4.38e-05	0.000316	CcSEcCtD
Irinotecan—Bradycardia—Topiramate—epilepsy syndrome	4.38e-05	0.000316	CcSEcCtD
Irinotecan—Malaise—Pregabalin—epilepsy syndrome	4.37e-05	0.000316	CcSEcCtD
Irinotecan—Nausea—Propofol—epilepsy syndrome	4.37e-05	0.000316	CcSEcCtD
Irinotecan—Vomiting—Fosphenytoin—epilepsy syndrome	4.36e-05	0.000315	CcSEcCtD
Irinotecan—Diarrhoea—Felbamate—epilepsy syndrome	4.36e-05	0.000315	CcSEcCtD
Irinotecan—Vertigo—Pregabalin—epilepsy syndrome	4.36e-05	0.000315	CcSEcCtD
Irinotecan—Abdominal pain—Lamotrigine—epilepsy syndrome	4.36e-05	0.000315	CcSEcCtD
Irinotecan—Body temperature increased—Lamotrigine—epilepsy syndrome	4.36e-05	0.000315	CcSEcCtD
Irinotecan—Dizziness—Diazepam—epilepsy syndrome	4.36e-05	0.000315	CcSEcCtD
Irinotecan—Infection—Valproic Acid—epilepsy syndrome	4.35e-05	0.000314	CcSEcCtD
Irinotecan—Syncope—Pregabalin—epilepsy syndrome	4.35e-05	0.000314	CcSEcCtD
Irinotecan—Leukopenia—Pregabalin—epilepsy syndrome	4.34e-05	0.000314	CcSEcCtD
Irinotecan—Rash—Fosphenytoin—epilepsy syndrome	4.33e-05	0.000313	CcSEcCtD
Irinotecan—Dermatitis—Fosphenytoin—epilepsy syndrome	4.32e-05	0.000312	CcSEcCtD
Irinotecan—Haemoglobin—Topiramate—epilepsy syndrome	4.32e-05	0.000312	CcSEcCtD
Irinotecan—Asthenia—Clonazepam—epilepsy syndrome	4.31e-05	0.000312	CcSEcCtD
Irinotecan—Rhinitis—Topiramate—epilepsy syndrome	4.31e-05	0.000311	CcSEcCtD
Irinotecan—Back pain—Gabapentin—epilepsy syndrome	4.3e-05	0.000311	CcSEcCtD
Irinotecan—Headache—Fosphenytoin—epilepsy syndrome	4.3e-05	0.000311	CcSEcCtD
Irinotecan—Haemorrhage—Topiramate—epilepsy syndrome	4.3e-05	0.000311	CcSEcCtD
Irinotecan—Nervous system disorder—Valproic Acid—epilepsy syndrome	4.29e-05	0.00031	CcSEcCtD
Irinotecan—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.29e-05	0.00031	CcSEcCtD
Irinotecan—Asthenia—Phenytoin—epilepsy syndrome	4.29e-05	0.00031	CcSEcCtD
Irinotecan—Nausea—Midazolam—epilepsy syndrome	4.28e-05	0.000309	CcSEcCtD
Irinotecan—Muscle spasms—Gabapentin—epilepsy syndrome	4.28e-05	0.000309	CcSEcCtD
Irinotecan—Diarrhoea—Zonisamide—epilepsy syndrome	4.27e-05	0.000308	CcSEcCtD
Irinotecan—Loss of consciousness—Pregabalin—epilepsy syndrome	4.26e-05	0.000308	CcSEcCtD
Irinotecan—Asthenia—Oxcarbazepine—epilepsy syndrome	4.26e-05	0.000308	CcSEcCtD
Irinotecan—Vomiting—Vigabatrin—epilepsy syndrome	4.25e-05	0.000307	CcSEcCtD
Irinotecan—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.23e-05	0.000306	CcSEcCtD
Irinotecan—Cough—Pregabalin—epilepsy syndrome	4.23e-05	0.000306	CcSEcCtD
Irinotecan—Connective tissue disorder—Topiramate—epilepsy syndrome	4.22e-05	0.000305	CcSEcCtD
Irinotecan—Nausea—Levetiracetam—epilepsy syndrome	4.22e-05	0.000305	CcSEcCtD
Irinotecan—Rash—Vigabatrin—epilepsy syndrome	4.22e-05	0.000305	CcSEcCtD
Irinotecan—Dizziness—Felbamate—epilepsy syndrome	4.22e-05	0.000305	CcSEcCtD
Irinotecan—Dermatitis—Vigabatrin—epilepsy syndrome	4.21e-05	0.000304	CcSEcCtD
Irinotecan—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.2e-05	0.000303	CcSEcCtD
Irinotecan—Headache—Vigabatrin—epilepsy syndrome	4.19e-05	0.000303	CcSEcCtD
Irinotecan—Hypertension—Pregabalin—epilepsy syndrome	4.19e-05	0.000303	CcSEcCtD
Irinotecan—Vomiting—Diazepam—epilepsy syndrome	4.19e-05	0.000303	CcSEcCtD
Irinotecan—Anorexia—Valproic Acid—epilepsy syndrome	4.17e-05	0.000302	CcSEcCtD
Irinotecan—Rash—Diazepam—epilepsy syndrome	4.15e-05	0.0003	CcSEcCtD
Irinotecan—Dermatitis—Diazepam—epilepsy syndrome	4.15e-05	0.0003	CcSEcCtD
Irinotecan—Visual impairment—Topiramate—epilepsy syndrome	4.14e-05	0.000299	CcSEcCtD
Irinotecan—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.13e-05	0.000298	CcSEcCtD
Irinotecan—Dizziness—Zonisamide—epilepsy syndrome	4.13e-05	0.000298	CcSEcCtD
Irinotecan—Headache—Diazepam—epilepsy syndrome	4.13e-05	0.000298	CcSEcCtD
Irinotecan—Diarrhoea—Clonazepam—epilepsy syndrome	4.11e-05	0.000297	CcSEcCtD
Irinotecan—Anaemia—Gabapentin—epilepsy syndrome	4.11e-05	0.000297	CcSEcCtD
Irinotecan—Hypotension—Valproic Acid—epilepsy syndrome	4.09e-05	0.000296	CcSEcCtD
Irinotecan—Asthenia—Carbamazepine—epilepsy syndrome	4.09e-05	0.000296	CcSEcCtD
Irinotecan—Diarrhoea—Phenytoin—epilepsy syndrome	4.09e-05	0.000295	CcSEcCtD
Irinotecan—Discomfort—Pregabalin—epilepsy syndrome	4.08e-05	0.000295	CcSEcCtD
Irinotecan—Nausea—Fosphenytoin—epilepsy syndrome	4.08e-05	0.000294	CcSEcCtD
Irinotecan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.07e-05	0.000294	CcSEcCtD
Irinotecan—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.06e-05	0.000293	CcSEcCtD
Irinotecan—Vomiting—Felbamate—epilepsy syndrome	4.05e-05	0.000293	CcSEcCtD
Irinotecan—Rash—Felbamate—epilepsy syndrome	4.02e-05	0.00029	CcSEcCtD
Irinotecan—Dermatitis—Felbamate—epilepsy syndrome	4.02e-05	0.00029	CcSEcCtD
Irinotecan—Malaise—Gabapentin—epilepsy syndrome	4.01e-05	0.00029	CcSEcCtD
Irinotecan—Vertigo—Gabapentin—epilepsy syndrome	4e-05	0.000289	CcSEcCtD
Irinotecan—Headache—Felbamate—epilepsy syndrome	3.99e-05	0.000288	CcSEcCtD
Irinotecan—Confusional state—Pregabalin—epilepsy syndrome	3.99e-05	0.000288	CcSEcCtD
Irinotecan—Flushing—Topiramate—epilepsy syndrome	3.99e-05	0.000288	CcSEcCtD
Irinotecan—Cardiac disorder—Topiramate—epilepsy syndrome	3.99e-05	0.000288	CcSEcCtD
Irinotecan—Syncope—Gabapentin—epilepsy syndrome	3.99e-05	0.000288	CcSEcCtD
Irinotecan—Leukopenia—Gabapentin—epilepsy syndrome	3.98e-05	0.000288	CcSEcCtD
Irinotecan—Dizziness—Clonazepam—epilepsy syndrome	3.98e-05	0.000287	CcSEcCtD
Irinotecan—Nausea—Vigabatrin—epilepsy syndrome	3.97e-05	0.000287	CcSEcCtD
Irinotecan—Vomiting—Zonisamide—epilepsy syndrome	3.97e-05	0.000287	CcSEcCtD
Irinotecan—Insomnia—Valproic Acid—epilepsy syndrome	3.96e-05	0.000286	CcSEcCtD
Irinotecan—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.96e-05	0.000286	CcSEcCtD
Irinotecan—Oedema—Pregabalin—epilepsy syndrome	3.96e-05	0.000286	CcSEcCtD
Irinotecan—Asthenia—Lamotrigine—epilepsy syndrome	3.95e-05	0.000286	CcSEcCtD
Irinotecan—Dizziness—Phenytoin—epilepsy syndrome	3.95e-05	0.000285	CcSEcCtD
Irinotecan—Rash—Zonisamide—epilepsy syndrome	3.93e-05	0.000284	CcSEcCtD
Irinotecan—Infection—Pregabalin—epilepsy syndrome	3.93e-05	0.000284	CcSEcCtD
Irinotecan—Paraesthesia—Valproic Acid—epilepsy syndrome	3.93e-05	0.000284	CcSEcCtD
Irinotecan—Dermatitis—Zonisamide—epilepsy syndrome	3.93e-05	0.000284	CcSEcCtD
Irinotecan—Dizziness—Oxcarbazepine—epilepsy syndrome	3.93e-05	0.000284	CcSEcCtD
Irinotecan—Nausea—Diazepam—epilepsy syndrome	3.91e-05	0.000283	CcSEcCtD
Irinotecan—Loss of consciousness—Gabapentin—epilepsy syndrome	3.91e-05	0.000282	CcSEcCtD
Irinotecan—Headache—Zonisamide—epilepsy syndrome	3.91e-05	0.000282	CcSEcCtD
Irinotecan—Dyspnoea—Valproic Acid—epilepsy syndrome	3.9e-05	0.000282	CcSEcCtD
Irinotecan—Diarrhoea—Carbamazepine—epilepsy syndrome	3.9e-05	0.000282	CcSEcCtD
Irinotecan—Angiopathy—Topiramate—epilepsy syndrome	3.9e-05	0.000282	CcSEcCtD
Irinotecan—Shock—Pregabalin—epilepsy syndrome	3.9e-05	0.000281	CcSEcCtD
Irinotecan—Somnolence—Valproic Acid—epilepsy syndrome	3.89e-05	0.000281	CcSEcCtD
Irinotecan—Immune system disorder—Topiramate—epilepsy syndrome	3.88e-05	0.00028	CcSEcCtD
Irinotecan—Nervous system disorder—Pregabalin—epilepsy syndrome	3.88e-05	0.00028	CcSEcCtD
Irinotecan—Cough—Gabapentin—epilepsy syndrome	3.88e-05	0.00028	CcSEcCtD
Irinotecan—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.88e-05	0.00028	CcSEcCtD
Irinotecan—Mediastinal disorder—Topiramate—epilepsy syndrome	3.87e-05	0.00028	CcSEcCtD
Irinotecan—Chills—Topiramate—epilepsy syndrome	3.86e-05	0.000279	CcSEcCtD
Irinotecan—Dyspepsia—Valproic Acid—epilepsy syndrome	3.85e-05	0.000278	CcSEcCtD
Irinotecan—Hypertension—Gabapentin—epilepsy syndrome	3.84e-05	0.000277	CcSEcCtD
Irinotecan—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.83e-05	0.000276	CcSEcCtD
Irinotecan—Vomiting—Clonazepam—epilepsy syndrome	3.82e-05	0.000276	CcSEcCtD
Irinotecan—Decreased appetite—Valproic Acid—epilepsy syndrome	3.81e-05	0.000275	CcSEcCtD
Irinotecan—Alopecia—Topiramate—epilepsy syndrome	3.8e-05	0.000274	CcSEcCtD
Irinotecan—Vomiting—Phenytoin—epilepsy syndrome	3.8e-05	0.000274	CcSEcCtD
Irinotecan—Rash—Clonazepam—epilepsy syndrome	3.79e-05	0.000274	CcSEcCtD
Irinotecan—Dermatitis—Clonazepam—epilepsy syndrome	3.79e-05	0.000274	CcSEcCtD
Irinotecan—Nausea—Felbamate—epilepsy syndrome	3.79e-05	0.000274	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.78e-05	0.000273	CcSEcCtD
Irinotecan—Vomiting—Oxcarbazepine—epilepsy syndrome	3.78e-05	0.000273	CcSEcCtD
Irinotecan—Fatigue—Valproic Acid—epilepsy syndrome	3.78e-05	0.000273	CcSEcCtD
Irinotecan—Anorexia—Pregabalin—epilepsy syndrome	3.77e-05	0.000273	CcSEcCtD
Irinotecan—Dizziness—Carbamazepine—epilepsy syndrome	3.77e-05	0.000272	CcSEcCtD
Irinotecan—Diarrhoea—Lamotrigine—epilepsy syndrome	3.77e-05	0.000272	CcSEcCtD
Irinotecan—Headache—Clonazepam—epilepsy syndrome	3.77e-05	0.000272	CcSEcCtD
Irinotecan—Rash—Phenytoin—epilepsy syndrome	3.77e-05	0.000272	CcSEcCtD
Irinotecan—Dermatitis—Phenytoin—epilepsy syndrome	3.76e-05	0.000272	CcSEcCtD
Irinotecan—Rash—Oxcarbazepine—epilepsy syndrome	3.75e-05	0.000271	CcSEcCtD
Irinotecan—Constipation—Valproic Acid—epilepsy syndrome	3.74e-05	0.000271	CcSEcCtD
Irinotecan—Pain—Valproic Acid—epilepsy syndrome	3.74e-05	0.000271	CcSEcCtD
Irinotecan—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.74e-05	0.00027	CcSEcCtD
Irinotecan—Headache—Phenytoin—epilepsy syndrome	3.74e-05	0.00027	CcSEcCtD
Irinotecan—Discomfort—Gabapentin—epilepsy syndrome	3.74e-05	0.00027	CcSEcCtD
Irinotecan—Headache—Oxcarbazepine—epilepsy syndrome	3.72e-05	0.000269	CcSEcCtD
Irinotecan—Nausea—Zonisamide—epilepsy syndrome	3.71e-05	0.000268	CcSEcCtD
Irinotecan—Hypotension—Pregabalin—epilepsy syndrome	3.7e-05	0.000267	CcSEcCtD
Irinotecan—Flatulence—Topiramate—epilepsy syndrome	3.69e-05	0.000266	CcSEcCtD
Irinotecan—Confusional state—Gabapentin—epilepsy syndrome	3.66e-05	0.000264	CcSEcCtD
Irinotecan—Dizziness—Lamotrigine—epilepsy syndrome	3.64e-05	0.000263	CcSEcCtD
Irinotecan—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.63e-05	0.000262	CcSEcCtD
Irinotecan—Oedema—Gabapentin—epilepsy syndrome	3.63e-05	0.000262	CcSEcCtD
Irinotecan—Vomiting—Carbamazepine—epilepsy syndrome	3.63e-05	0.000262	CcSEcCtD
Irinotecan—Back pain—Topiramate—epilepsy syndrome	3.62e-05	0.000261	CcSEcCtD
Irinotecan—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.61e-05	0.000261	CcSEcCtD
Irinotecan—Infection—Gabapentin—epilepsy syndrome	3.61e-05	0.000261	CcSEcCtD
Irinotecan—Muscle spasms—Topiramate—epilepsy syndrome	3.6e-05	0.00026	CcSEcCtD
Irinotecan—Rash—Carbamazepine—epilepsy syndrome	3.6e-05	0.00026	CcSEcCtD
Irinotecan—Dermatitis—Carbamazepine—epilepsy syndrome	3.59e-05	0.000259	CcSEcCtD
Irinotecan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.58e-05	0.000259	CcSEcCtD
Irinotecan—Insomnia—Pregabalin—epilepsy syndrome	3.58e-05	0.000259	CcSEcCtD
Irinotecan—Nausea—Clonazepam—epilepsy syndrome	3.57e-05	0.000258	CcSEcCtD
Irinotecan—Headache—Carbamazepine—epilepsy syndrome	3.57e-05	0.000258	CcSEcCtD
Irinotecan—Shock—Gabapentin—epilepsy syndrome	3.57e-05	0.000258	CcSEcCtD
Irinotecan—Nervous system disorder—Gabapentin—epilepsy syndrome	3.56e-05	0.000257	CcSEcCtD
Irinotecan—Paraesthesia—Pregabalin—epilepsy syndrome	3.56e-05	0.000257	CcSEcCtD
Irinotecan—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.55e-05	0.000257	CcSEcCtD
Irinotecan—Nausea—Phenytoin—epilepsy syndrome	3.55e-05	0.000256	CcSEcCtD
Irinotecan—Dyspnoea—Pregabalin—epilepsy syndrome	3.53e-05	0.000255	CcSEcCtD
Irinotecan—Nausea—Oxcarbazepine—epilepsy syndrome	3.53e-05	0.000255	CcSEcCtD
Irinotecan—Somnolence—Pregabalin—epilepsy syndrome	3.52e-05	0.000254	CcSEcCtD
Irinotecan—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.51e-05	0.000254	CcSEcCtD
Irinotecan—Vomiting—Lamotrigine—epilepsy syndrome	3.5e-05	0.000253	CcSEcCtD
Irinotecan—Rash—Lamotrigine—epilepsy syndrome	3.47e-05	0.000251	CcSEcCtD
Irinotecan—Ill-defined disorder—Topiramate—epilepsy syndrome	3.47e-05	0.000251	CcSEcCtD
Irinotecan—Dermatitis—Lamotrigine—epilepsy syndrome	3.47e-05	0.000251	CcSEcCtD
Irinotecan—Abdominal pain—Valproic Acid—epilepsy syndrome	3.46e-05	0.00025	CcSEcCtD
Irinotecan—Body temperature increased—Valproic Acid—epilepsy syndrome	3.46e-05	0.00025	CcSEcCtD
Irinotecan—Anorexia—Gabapentin—epilepsy syndrome	3.46e-05	0.00025	CcSEcCtD
Irinotecan—Anaemia—Topiramate—epilepsy syndrome	3.46e-05	0.00025	CcSEcCtD
Irinotecan—Headache—Lamotrigine—epilepsy syndrome	3.45e-05	0.000249	CcSEcCtD
Irinotecan—Decreased appetite—Pregabalin—epilepsy syndrome	3.44e-05	0.000249	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.42e-05	0.000247	CcSEcCtD
Irinotecan—Fatigue—Pregabalin—epilepsy syndrome	3.41e-05	0.000247	CcSEcCtD
Irinotecan—Hypotension—Gabapentin—epilepsy syndrome	3.39e-05	0.000245	CcSEcCtD
Irinotecan—Nausea—Carbamazepine—epilepsy syndrome	3.39e-05	0.000245	CcSEcCtD
Irinotecan—Pain—Pregabalin—epilepsy syndrome	3.39e-05	0.000245	CcSEcCtD
Irinotecan—Constipation—Pregabalin—epilepsy syndrome	3.39e-05	0.000245	CcSEcCtD
Irinotecan—Malaise—Topiramate—epilepsy syndrome	3.37e-05	0.000244	CcSEcCtD
Irinotecan—Vertigo—Topiramate—epilepsy syndrome	3.36e-05	0.000243	CcSEcCtD
Irinotecan—Syncope—Topiramate—epilepsy syndrome	3.36e-05	0.000242	CcSEcCtD
Irinotecan—Leukopenia—Topiramate—epilepsy syndrome	3.35e-05	0.000242	CcSEcCtD
Irinotecan—Loss of consciousness—Topiramate—epilepsy syndrome	3.29e-05	0.000238	CcSEcCtD
Irinotecan—Insomnia—Gabapentin—epilepsy syndrome	3.28e-05	0.000237	CcSEcCtD
Irinotecan—Nausea—Lamotrigine—epilepsy syndrome	3.27e-05	0.000236	CcSEcCtD
Irinotecan—Cough—Topiramate—epilepsy syndrome	3.27e-05	0.000236	CcSEcCtD
Irinotecan—Feeling abnormal—Pregabalin—epilepsy syndrome	3.26e-05	0.000236	CcSEcCtD
Irinotecan—Paraesthesia—Gabapentin—epilepsy syndrome	3.26e-05	0.000235	CcSEcCtD
Irinotecan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.24e-05	0.000234	CcSEcCtD
Irinotecan—Dyspnoea—Gabapentin—epilepsy syndrome	3.24e-05	0.000234	CcSEcCtD
Irinotecan—Hypertension—Topiramate—epilepsy syndrome	3.23e-05	0.000233	CcSEcCtD
Irinotecan—Somnolence—Gabapentin—epilepsy syndrome	3.23e-05	0.000233	CcSEcCtD
Irinotecan—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.23e-05	0.000233	CcSEcCtD
Irinotecan—Dyspepsia—Gabapentin—epilepsy syndrome	3.2e-05	0.000231	CcSEcCtD
Irinotecan—Decreased appetite—Gabapentin—epilepsy syndrome	3.16e-05	0.000228	CcSEcCtD
Irinotecan—Discomfort—Topiramate—epilepsy syndrome	3.15e-05	0.000227	CcSEcCtD
Irinotecan—Asthenia—Valproic Acid—epilepsy syndrome	3.14e-05	0.000227	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.13e-05	0.000226	CcSEcCtD
Irinotecan—Fatigue—Gabapentin—epilepsy syndrome	3.13e-05	0.000226	CcSEcCtD
Irinotecan—Body temperature increased—Pregabalin—epilepsy syndrome	3.13e-05	0.000226	CcSEcCtD
Irinotecan—Abdominal pain—Pregabalin—epilepsy syndrome	3.13e-05	0.000226	CcSEcCtD
Irinotecan—Pain—Gabapentin—epilepsy syndrome	3.1e-05	0.000224	CcSEcCtD
Irinotecan—Constipation—Gabapentin—epilepsy syndrome	3.1e-05	0.000224	CcSEcCtD
Irinotecan—Confusional state—Topiramate—epilepsy syndrome	3.08e-05	0.000222	CcSEcCtD
Irinotecan—Oedema—Topiramate—epilepsy syndrome	3.05e-05	0.000221	CcSEcCtD
Irinotecan—Infection—Topiramate—epilepsy syndrome	3.03e-05	0.000219	CcSEcCtD
Irinotecan—Shock—Topiramate—epilepsy syndrome	3e-05	0.000217	CcSEcCtD
Irinotecan—Diarrhoea—Valproic Acid—epilepsy syndrome	3e-05	0.000216	CcSEcCtD
Irinotecan—Nervous system disorder—Topiramate—epilepsy syndrome	3e-05	0.000216	CcSEcCtD
Irinotecan—Feeling abnormal—Gabapentin—epilepsy syndrome	2.99e-05	0.000216	CcSEcCtD
Irinotecan—Thrombocytopenia—Topiramate—epilepsy syndrome	2.99e-05	0.000216	CcSEcCtD
Irinotecan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.97e-05	0.000214	CcSEcCtD
Irinotecan—Hyperhidrosis—Topiramate—epilepsy syndrome	2.95e-05	0.000213	CcSEcCtD
Irinotecan—Hypersensitivity—Pregabalin—epilepsy syndrome	2.92e-05	0.000211	CcSEcCtD
Irinotecan—Anorexia—Topiramate—epilepsy syndrome	2.91e-05	0.00021	CcSEcCtD
Irinotecan—Dizziness—Valproic Acid—epilepsy syndrome	2.9e-05	0.000209	CcSEcCtD
Irinotecan—Abdominal pain—Gabapentin—epilepsy syndrome	2.87e-05	0.000207	CcSEcCtD
Irinotecan—Body temperature increased—Gabapentin—epilepsy syndrome	2.87e-05	0.000207	CcSEcCtD
Irinotecan—Hypotension—Topiramate—epilepsy syndrome	2.85e-05	0.000206	CcSEcCtD
Irinotecan—Asthenia—Pregabalin—epilepsy syndrome	2.84e-05	0.000205	CcSEcCtD
Irinotecan—Vomiting—Valproic Acid—epilepsy syndrome	2.78e-05	0.000201	CcSEcCtD
Irinotecan—Insomnia—Topiramate—epilepsy syndrome	2.76e-05	0.0002	CcSEcCtD
Irinotecan—Rash—Valproic Acid—epilepsy syndrome	2.76e-05	0.000199	CcSEcCtD
Irinotecan—Dermatitis—Valproic Acid—epilepsy syndrome	2.76e-05	0.000199	CcSEcCtD
Irinotecan—Headache—Valproic Acid—epilepsy syndrome	2.74e-05	0.000198	CcSEcCtD
Irinotecan—Paraesthesia—Topiramate—epilepsy syndrome	2.74e-05	0.000198	CcSEcCtD
Irinotecan—Dyspnoea—Topiramate—epilepsy syndrome	2.72e-05	0.000197	CcSEcCtD
Irinotecan—Somnolence—Topiramate—epilepsy syndrome	2.72e-05	0.000196	CcSEcCtD
Irinotecan—Diarrhoea—Pregabalin—epilepsy syndrome	2.71e-05	0.000196	CcSEcCtD
Irinotecan—Dyspepsia—Topiramate—epilepsy syndrome	2.69e-05	0.000194	CcSEcCtD
Irinotecan—Hypersensitivity—Gabapentin—epilepsy syndrome	2.67e-05	0.000193	CcSEcCtD
Irinotecan—Decreased appetite—Topiramate—epilepsy syndrome	2.66e-05	0.000192	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.64e-05	0.00019	CcSEcCtD
Irinotecan—Fatigue—Topiramate—epilepsy syndrome	2.63e-05	0.00019	CcSEcCtD
Irinotecan—Dizziness—Pregabalin—epilepsy syndrome	2.62e-05	0.000189	CcSEcCtD
Irinotecan—Pain—Topiramate—epilepsy syndrome	2.61e-05	0.000189	CcSEcCtD
Irinotecan—Constipation—Topiramate—epilepsy syndrome	2.61e-05	0.000189	CcSEcCtD
Irinotecan—Asthenia—Gabapentin—epilepsy syndrome	2.6e-05	0.000188	CcSEcCtD
Irinotecan—Nausea—Valproic Acid—epilepsy syndrome	2.6e-05	0.000188	CcSEcCtD
Irinotecan—Vomiting—Pregabalin—epilepsy syndrome	2.52e-05	0.000182	CcSEcCtD
Irinotecan—Feeling abnormal—Topiramate—epilepsy syndrome	2.52e-05	0.000182	CcSEcCtD
Irinotecan—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.5e-05	0.00018	CcSEcCtD
Irinotecan—Rash—Pregabalin—epilepsy syndrome	2.5e-05	0.00018	CcSEcCtD
Irinotecan—Dermatitis—Pregabalin—epilepsy syndrome	2.49e-05	0.00018	CcSEcCtD
Irinotecan—Diarrhoea—Gabapentin—epilepsy syndrome	2.48e-05	0.000179	CcSEcCtD
Irinotecan—Headache—Pregabalin—epilepsy syndrome	2.48e-05	0.000179	CcSEcCtD
Irinotecan—Body temperature increased—Topiramate—epilepsy syndrome	2.41e-05	0.000174	CcSEcCtD
Irinotecan—Abdominal pain—Topiramate—epilepsy syndrome	2.41e-05	0.000174	CcSEcCtD
Irinotecan—Dizziness—Gabapentin—epilepsy syndrome	2.4e-05	0.000173	CcSEcCtD
Irinotecan—Nausea—Pregabalin—epilepsy syndrome	2.35e-05	0.00017	CcSEcCtD
Irinotecan—Vomiting—Gabapentin—epilepsy syndrome	2.31e-05	0.000167	CcSEcCtD
Irinotecan—Rash—Gabapentin—epilepsy syndrome	2.29e-05	0.000165	CcSEcCtD
Irinotecan—Dermatitis—Gabapentin—epilepsy syndrome	2.29e-05	0.000165	CcSEcCtD
Irinotecan—Headache—Gabapentin—epilepsy syndrome	2.27e-05	0.000164	CcSEcCtD
Irinotecan—Hypersensitivity—Topiramate—epilepsy syndrome	2.25e-05	0.000163	CcSEcCtD
Irinotecan—Asthenia—Topiramate—epilepsy syndrome	2.19e-05	0.000158	CcSEcCtD
Irinotecan—Nausea—Gabapentin—epilepsy syndrome	2.16e-05	0.000156	CcSEcCtD
Irinotecan—Diarrhoea—Topiramate—epilepsy syndrome	2.09e-05	0.000151	CcSEcCtD
Irinotecan—Dizziness—Topiramate—epilepsy syndrome	2.02e-05	0.000146	CcSEcCtD
Irinotecan—Vomiting—Topiramate—epilepsy syndrome	1.94e-05	0.00014	CcSEcCtD
Irinotecan—Rash—Topiramate—epilepsy syndrome	1.93e-05	0.000139	CcSEcCtD
Irinotecan—Dermatitis—Topiramate—epilepsy syndrome	1.92e-05	0.000139	CcSEcCtD
Irinotecan—Headache—Topiramate—epilepsy syndrome	1.91e-05	0.000138	CcSEcCtD
Irinotecan—Nausea—Topiramate—epilepsy syndrome	1.81e-05	0.000131	CcSEcCtD
Irinotecan—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	3.65e-06	4.92e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FYN—epilepsy syndrome	3.64e-06	4.9e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.64e-06	4.9e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	3.63e-06	4.89e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AGT—epilepsy syndrome	3.63e-06	4.89e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—H2AFX—epilepsy syndrome	3.63e-06	4.88e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CAT—epilepsy syndrome	3.61e-06	4.86e-05	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	3.59e-06	4.84e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	3.58e-06	4.82e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.56e-06	4.79e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—APOE—epilepsy syndrome	3.56e-06	4.79e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	3.55e-06	4.78e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	3.54e-06	4.77e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PLCB1—epilepsy syndrome	3.54e-06	4.77e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—TH—epilepsy syndrome	3.53e-06	4.75e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ABCB1—epilepsy syndrome	3.51e-06	4.72e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	3.51e-06	4.72e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—YWHAZ—epilepsy syndrome	3.5e-06	4.71e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—TH—epilepsy syndrome	3.49e-06	4.71e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PLAU—epilepsy syndrome	3.48e-06	4.69e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—HMOX1—epilepsy syndrome	3.47e-06	4.67e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—HMOX1—epilepsy syndrome	3.47e-06	4.67e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CHRM3—epilepsy syndrome	3.43e-06	4.61e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—KCNJ11—epilepsy syndrome	3.43e-06	4.61e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CAT—epilepsy syndrome	3.42e-06	4.61e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CAT—epilepsy syndrome	3.42e-06	4.61e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	3.42e-06	4.6e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.4e-06	4.57e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.37e-06	4.55e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.37e-06	4.55e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.37e-06	4.55e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.37e-06	4.55e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.37e-06	4.55e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.37e-06	4.53e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CCR5—epilepsy syndrome	3.36e-06	4.53e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—HMOX1—epilepsy syndrome	3.34e-06	4.5e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ABCB1—epilepsy syndrome	3.33e-06	4.48e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ABCB1—epilepsy syndrome	3.33e-06	4.48e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AQP1—epilepsy syndrome	3.32e-06	4.47e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	3.32e-06	4.47e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CAT—epilepsy syndrome	3.3e-06	4.44e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GPX1—epilepsy syndrome	3.26e-06	4.39e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—HMOX1—epilepsy syndrome	3.26e-06	4.39e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	3.24e-06	4.37e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PRKCB—epilepsy syndrome	3.24e-06	4.36e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	3.23e-06	4.35e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CAT—epilepsy syndrome	3.22e-06	4.33e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	3.21e-06	4.33e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ABCB1—epilepsy syndrome	3.21e-06	4.32e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NOS2—epilepsy syndrome	3.2e-06	4.31e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.19e-06	4.3e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	3.18e-06	4.28e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	3.16e-06	4.26e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	3.14e-06	4.23e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CAT—epilepsy syndrome	3.14e-06	4.22e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ABCB1—epilepsy syndrome	3.13e-06	4.21e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TSC2—epilepsy syndrome	3.13e-06	4.21e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.13e-06	4.21e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GPX1—epilepsy syndrome	3.09e-06	4.17e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GPX1—epilepsy syndrome	3.09e-06	4.17e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.09e-06	4.16e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.09e-06	4.16e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.09e-06	4.16e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APOE—epilepsy syndrome	3.06e-06	4.12e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—POMC—epilepsy syndrome	3.06e-06	4.12e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	3.05e-06	4.11e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.03e-06	4.09e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3e-06	4.04e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3e-06	4.04e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GPX1—epilepsy syndrome	2.98e-06	4.02e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.97e-06	4e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—HMOX1—epilepsy syndrome	2.94e-06	3.96e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	2.92e-06	3.93e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GPX1—epilepsy syndrome	2.91e-06	3.92e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CAT—epilepsy syndrome	2.9e-06	3.91e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	2.9e-06	3.9e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CAT—epilepsy syndrome	2.88e-06	3.88e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6ST—epilepsy syndrome	2.88e-06	3.87e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.87e-06	3.86e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.87e-06	3.86e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AGT—epilepsy syndrome	2.86e-06	3.85e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NOS2—epilepsy syndrome	2.85e-06	3.84e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	2.84e-06	3.82e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.83e-06	3.82e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ABCB1—epilepsy syndrome	2.82e-06	3.8e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—APOE—epilepsy syndrome	2.8e-06	3.77e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	2.8e-06	3.77e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ABCG2—epilepsy syndrome	2.79e-06	3.76e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ALB—epilepsy syndrome	2.79e-06	3.75e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	2.76e-06	3.72e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—BCHE—epilepsy syndrome	2.75e-06	3.7e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP2C19—epilepsy syndrome	2.72e-06	3.66e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AGT—epilepsy syndrome	2.71e-06	3.65e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AGT—epilepsy syndrome	2.71e-06	3.65e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP11A1—epilepsy syndrome	2.7e-06	3.64e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.7e-06	3.63e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.7e-06	3.63e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.69e-06	3.62e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.69e-06	3.62e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—APOE—epilepsy syndrome	2.66e-06	3.58e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—APOE—epilepsy syndrome	2.66e-06	3.58e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GPX1—epilepsy syndrome	2.63e-06	3.54e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.62e-06	3.53e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	2.62e-06	3.53e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AGT—epilepsy syndrome	2.62e-06	3.52e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GPX1—epilepsy syndrome	2.6e-06	3.5e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	2.59e-06	3.49e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TH—epilepsy syndrome	2.58e-06	3.48e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—APOE—epilepsy syndrome	2.56e-06	3.45e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.56e-06	3.45e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.56e-06	3.44e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.56e-06	3.44e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AGT—epilepsy syndrome	2.55e-06	3.44e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.54e-06	3.41e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TH—epilepsy syndrome	2.53e-06	3.4e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—APOE—epilepsy syndrome	2.5e-06	3.37e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AGT—epilepsy syndrome	2.49e-06	3.35e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.45e-06	3.3e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP2D6—epilepsy syndrome	2.44e-06	3.29e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.44e-06	3.29e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.44e-06	3.29e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—epilepsy syndrome	2.44e-06	3.28e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—APOE—epilepsy syndrome	2.44e-06	3.28e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—POMC—epilepsy syndrome	2.41e-06	3.24e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.39e-06	3.22e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.38e-06	3.21e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.37e-06	3.19e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.34e-06	3.15e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FGF2—epilepsy syndrome	2.33e-06	3.13e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ADRA2A—epilepsy syndrome	2.32e-06	3.13e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—BCHE—epilepsy syndrome	2.31e-06	3.12e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AGT—epilepsy syndrome	2.3e-06	3.1e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.29e-06	3.09e-05	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.29e-06	3.09e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—POMC—epilepsy syndrome	2.28e-06	3.08e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—POMC—epilepsy syndrome	2.28e-06	3.08e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AGT—epilepsy syndrome	2.28e-06	3.07e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.26e-06	3.04e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—APOE—epilepsy syndrome	2.26e-06	3.04e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.25e-06	3.03e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—APOE—epilepsy syndrome	2.24e-06	3.01e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC2A1—epilepsy syndrome	2.21e-06	2.97e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—POMC—epilepsy syndrome	2.2e-06	2.97e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ALB—epilepsy syndrome	2.19e-06	2.96e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PLCB1—epilepsy syndrome	2.18e-06	2.94e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TH—epilepsy syndrome	2.18e-06	2.93e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	2.16e-06	2.9e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—POMC—epilepsy syndrome	2.15e-06	2.89e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.14e-06	2.88e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.14e-06	2.88e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CAT—epilepsy syndrome	2.13e-06	2.87e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MTOR—epilepsy syndrome	2.12e-06	2.85e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.11e-06	2.84e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.11e-06	2.84e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—epilepsy syndrome	2.1e-06	2.82e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.09e-06	2.82e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ALB—epilepsy syndrome	2.08e-06	2.8e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ALB—epilepsy syndrome	2.08e-06	2.8e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.08e-06	2.8e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	2.07e-06	2.79e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.04e-06	2.75e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.04e-06	2.75e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.04e-06	2.74e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.03e-06	2.73e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.02e-06	2.73e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ALB—epilepsy syndrome	2.01e-06	2.7e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ALB—epilepsy syndrome	1.96e-06	2.64e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—POMC—epilepsy syndrome	1.94e-06	2.61e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.93e-06	2.6e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.92e-06	2.59e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.92e-06	2.59e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—epilepsy syndrome	1.92e-06	2.59e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.91e-06	2.58e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALB—epilepsy syndrome	1.91e-06	2.57e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TH—epilepsy syndrome	1.91e-06	2.57e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SRC—epilepsy syndrome	1.9e-06	2.56e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.88e-06	2.53e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.85e-06	2.5e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.85e-06	2.49e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.85e-06	2.49e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	1.82e-06	2.45e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	1.82e-06	2.45e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—HMOX1—epilepsy syndrome	1.82e-06	2.45e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CAT—epilepsy syndrome	1.79e-06	2.41e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALB—epilepsy syndrome	1.77e-06	2.38e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—epilepsy syndrome	1.76e-06	2.37e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.75e-06	2.36e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ABCB1—epilepsy syndrome	1.74e-06	2.35e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—epilepsy syndrome	1.71e-06	2.31e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SRC—epilepsy syndrome	1.7e-06	2.28e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.69e-06	2.27e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	1.67e-06	2.25e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.65e-06	2.23e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.65e-06	2.22e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GPX1—epilepsy syndrome	1.62e-06	2.18e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.62e-06	2.18e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.59e-06	2.14e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CAT—epilepsy syndrome	1.57e-06	2.11e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.55e-06	2.08e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.53e-06	2.06e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.51e-06	2.03e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.47e-06	1.98e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.46e-06	1.97e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AGT—epilepsy syndrome	1.42e-06	1.91e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.42e-06	1.91e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.42e-06	1.91e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—APOE—epilepsy syndrome	1.39e-06	1.87e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.39e-06	1.87e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.32e-06	1.77e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.3e-06	1.74e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.27e-06	1.7e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.25e-06	1.69e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.25e-06	1.68e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AGT—epilepsy syndrome	1.24e-06	1.68e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—epilepsy syndrome	1.23e-06	1.65e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—APOE—epilepsy syndrome	1.22e-06	1.64e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—POMC—epilepsy syndrome	1.2e-06	1.61e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.19e-06	1.6e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—epilepsy syndrome	1.18e-06	1.59e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.18e-06	1.59e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TH—epilepsy syndrome	1.17e-06	1.58e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	1.13e-06	1.53e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.11e-06	1.49e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—epilepsy syndrome	1.05e-06	1.42e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—POMC—epilepsy syndrome	1.05e-06	1.41e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.8e-07	1.32e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CAT—epilepsy syndrome	9.67e-07	1.3e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—epilepsy syndrome	9.65e-07	1.3e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALB—epilepsy syndrome	9.55e-07	1.29e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—epilepsy syndrome	9.54e-07	1.28e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.41e-07	1.27e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—epilepsy syndrome	9.16e-07	1.23e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—epilepsy syndrome	9.16e-07	1.23e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—epilepsy syndrome	8.83e-07	1.19e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.75e-07	1.18e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—epilepsy syndrome	8.61e-07	1.16e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	8.39e-07	1.13e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—epilepsy syndrome	8.36e-07	1.13e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—epilepsy syndrome	7.77e-07	1.05e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—epilepsy syndrome	7.7e-07	1.04e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.67e-07	1.03e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.51e-07	1.01e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.45e-07	8.69e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.89e-07	7.93e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—epilepsy syndrome	5.69e-07	7.67e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—epilepsy syndrome	5.57e-07	7.5e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.15e-07	6.93e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—epilepsy syndrome	4.79e-07	6.46e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.2e-07	5.66e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.59e-07	3.49e-06	CbGpPWpGaD
